Cholecystokinin-dopamine intearctions
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 12 (6) , 232-236
- https://doi.org/10.1016/0165-6147(91)90558-a
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cholecystokinin Modulates the Release of Dopamine from the Anterior and Posterior Nucleus Accumbens by Two Different MechanismsJournal of Neurochemistry, 1991
- Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptorPharmacology Biochemistry and Behavior, 1989
- Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: Evidence for rostral-caudal differences in accumbens CCK function.Behavioral Neuroscience, 1989
- Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonistsJournal of Medicinal Chemistry, 1989
- Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disordersJournal of Psychopharmacology, 1989
- Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotionSynapse, 1989
- Reduced Cholecystokinin Levels in Cerebrospinal Fluid of Parkinsonian and Schizophrenic Patients Effect of Ceruletide in SchizophreniaaAnnals of the New York Academy of Sciences, 1985
- Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the ratBrain Research, 1985
- Dopamine receptor elevation by cholecystokininPeptides, 1984
- Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesionsLife Sciences, 1983